Cardiomyopathy Terminated Phase Trials for Ranolazine (DB00243)
Also known as: Cardiomyopathies / Cardiomyopathy, unspecified / Myocardial degeneration / Myocardial disease (disorder) / Cardiomyopathy NOS / Cardiomyopathy (disorder) / Myocardiodystrophy
Indication | Status | Phase |
---|---|---|
DBCOND0007414 (Cardiomyopathy) | Terminated | Not Available |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT01705509 | The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC) | Supportive Care |